Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Appetite control: hormones or diet strategies
Semaglutida sublingual Comprimido diario, sin necesidad de agujas
Weight-related comorbidities that lower the BMI threshold If your BMI is 27.0-29.9, you qualify for Mounjaro if you have at least one of these conditions: Cardiovascular and metabolic: Hypertension (blood pressure 130/80 mmHg or higher, or on antihypertensive medication) Dyslipidemia (LDL 130 mg/dL or higher, triglycerides 150 mg/dL or higher, or on statin therapy) Type 2 diabetes (this moves you to the diabetes pathway, which has no BMI minimum) Prediabetes (A1C 5.7%-6.4% or fasting glucose 100-125 mg/dL) Coronary artery disease History of stroke or transient ischemic attack Respiratory: Obstructive sleep apnea (diagnosed by sleep study, not just symptoms) Obesity hypoventilation syndrome Musculoskeletal: Osteoarthritis with documented functional impairment Chronic lower back pain attributable to excess weight Metabolic: Non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH) Polycystic ovary syndrome (PCOS) Reproductive: Infertility related to anovulation and obesity The comorbidity must be documented in your medical record
This is called metabolic adaptation, not metabolic damage, and is a natural response to a calorie deficit
The result is a serum that actually penetrates deep into the skin rather than sitting on the surface which is why results are visible and lasting, not temporary
Heres what you can expect: Wegovy : People taking Wegovy lost an average of 15% of their body weight over 68 weeks
